Results 151 to 160 of about 159,964 (350)

Current Aspects of Prognosis, Differential Diagnosis, and Spasmolytic Therapy in Gallstone Disease

Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to analyze current aspects of prognosis, differential diagnosis, and spasmolytic therapy in gallstone disease.Key points. The prevalence of gallstone disease in the Russian Federation remains considerably high.
V. V. Tsukanov, Ju. L. Tonkikh, A. V. Vasyutin   +2 more
doaj   +1 more source

Supplementary Figure Legends from Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer [PDF]

, 2023
Atsushi Aruga, Nobuhiro Takeshita, Yoshihito Kotera, Ryuji Okuyama, Norimasa Matsushita, Takehiro Ohta, Kazuyoshi Takeda, Masakazu Yamamoto   +7 more
openalex   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source

Surgical management of biliary tract cancers

, 2016
Mark Fairweather, Vinod P. Balachandran, Michael I. D’Angelica   +2 more
openalex   +1 more source

Does radiotherapy still have a role in unresected biliary tract cancer? [PDF]

, 2016
Erqi L. Pollom, Muthuraman Alagappan, Lesley S. Park, Alice S. Whittemore, Albert C. Koong, Daniel T. Chang   +5 more
openalex   +1 more source

Diagnostic Role of Bile Pigment Components in Biliary Tract Cancer

, 2023
Keun Soo Ahn, Koo Jeong Kang, Yong‐Hoon Kim, Tae‐Seok Kim, Kwang Bum Cho, Hye Soon Kim, Won‐Ki Baek, Seong‐Il Suh, Jin‐Yi Han   +8 more
openalex   +2 more sources

Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions

Interdisciplinary Medicine, EarlyView.
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu   +6 more
wiley   +1 more source

Targeting mTOR signaling for the treatment of intrahepatic cholangiocarcinoma with TSC1/ARID1A mutations: a case report with an unexpected response

Therapeutic Advances in Medical Oncology
Biliary tract cancer incidence is increasing and the prognostic remains dismal. The development of personalized medicine is a pivotal issue in proposing therapeutic options for biliary tract cancer patients.
Clémentine Daugan, Romain Boidot, François Ghiringhelli, Christophe Borg, Angélique Vienot   +4 more
doaj   +1 more source

Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: A meta-analysis

, 2014
Heng Liu, Qidi Zhang, Zhenghong Li, Qingqing Zhang, Lungen Lu   +4 more
openalex   +2 more sources

Chronic Low‐Dose Unsymmetrical Dimethylhydrazine Exposure in Rats: Multiorgan Mechanisms and Biomarker Identification

Journal of Applied Toxicology, EarlyView.
ABSTRACT Unsymmetrical dimethylhydrazine (UDMH), a highly toxic rocket propellant with known multiorgan effects, requires urgent characterization of its chronic low‐dose toxicity. Using an integrated approach including exploratory transcriptomics (n = 3/group) and metabolomic (n = 4/group) approaches in male Sprague–Dawley rats exposed to high‐dose ...
Fuzhou Liu, Bing Liu, Keli Wang, Xiaoyu Wang, Zhen Sun, Xiaojuan Pan, Zengming Zhao   +6 more
wiley   +1 more source